{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:22Z","timestamp":1753891882245,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Sarcomatoid urothelial carcinoma of the renal pelvis is an extremely rare malignant tumor with a high risk of recurrence and metastasis and a poor prognosis. This case reports a 61-year-old male patient with renal pelvic sarcomatoid urothelial carcinoma who developed extensive lymph node metastasis 26 days after posterior laparoscopic radical nephrectomy for renal carcinoma, and the patient died on the 45th postoperative day, with the cause of death being advanced malignancy of the tumor. This case highlights the rapid progression of sarcomatoid urothelial carcinoma, and sarcomatoid variants should be identified as early as possible, with active multidisciplinary adjuvant therapy and closer follow-up when feasible. Retrospective analysis of this patient\u2019s treatment regimen and admission provides lessons for recognizing and aggressively managing this rare and fatal variant of urothelial carcinoma.<\/jats:p>","DOI":"10.3389\/fonc.2025.1480790","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:18:01Z","timestamp":1740633481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in diagnosing and managing sarcomatoid urothelial carcinoma of the renal pelvis: a case report"],"prefix":"10.3389","volume":"15","author":[{"given":"Jian","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayong","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xike","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.16150\/j.1671-2870.2023.03.13","article-title":"Clinicopathological features of urothelial carcinoma","author":"Zhou","year":"2023","journal-title":"J Diagnostics Concepts Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.21037\/tau-20-1472","article-title":"Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review","volume":"10","author":"Giudici","year":"2021","journal-title":"Transl Androl Urol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2023.01.017","article-title":"Variant histology in upper tract carcinomas: Analysis of the National Cancer Database","volume":"41","author":"Song","year":"2023","journal-title":"\u201d Urologic Oncol vol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1038\/s41598-024-61748-2","article-title":"A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020","volume":"14","author":"Mousavi","year":"2024","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061115","article-title":"Upper tract urothelial cancer: guideline of guidelines","volume":"16","author":"Pandolfo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45610","article-title":"Carcinosarcoma arising from the renal pelvis: A rare case report","volume":"15","author":"Hac\u0131osmano\u011flu","year":"2023","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235558","article-title":"Clinical and biological differences between upper tract carcinoma and bladder urothelial cancer, including implications for clinical practice","volume":"15","author":"Lefort","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2022.41.233.31688","article-title":"Sarcomatoid variant of urothelial carcinoma in the renal pelvis with brain metastasis: a case report","volume":"41","author":"Nasrollahi","year":"2022","journal-title":"Pan Afr Med J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205040","article-title":"Imaging in upper tract urothelial carcinoma: A review","volume":"15","author":"Tsikitas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115027","article-title":"Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications","volume":"165","author":"Wu","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/2374289520958172","article-title":"Educational case: urothelial carcinoma: an overview of pathologic diagnosis","volume":"7","author":"Willner","year":"2020","journal-title":"Acad Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.56679","article-title":"Exploring the rare case of a sarcomatoid variant of urothelial carcinoma","volume":"16","author":"A","year":"2024","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2145","article-title":"Diagnosis and\u00a0treatment of carcinosarcoma of the renal pelvis: A case report","volume":"8","author":"Dong","year":"2014","journal-title":"Oncol Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.23736\/S0393-2249.18.03192-2","article-title":"Clinical and histopathological features of carcinosarcoma of the renal pelvis: a systematic review of a rare tumor","volume":"71","author":"Mantica","year":"2019","journal-title":"Minerva Urol Nefrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/tau-22-882","article-title":"Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review","volume":"12","author":"Grob","year":"2023","journal-title":"Transl Androl Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010044","article-title":"Upper tract urothelial carcinoma: A narrative review of current surveillance strategies for non-metastatic disease","volume":"16","author":"Klemm","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21037\/tau-23-123","article-title":"Narrative review of nephron-sparing surgical\u00a0management of upper tract urothelial carcinoma: is there a role for distal ureterectomy, segmental ureterectomy, and partial nephrectomy","volume":"13","author":"Saini","year":"2024","journal-title":"Transl Androl Urol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101931","article-title":"The utility of intraluminal therapies in upper tract urothelial carcinoma: A narrative review","volume":"16","author":"Tyrrell","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6051.22.04659-6","article-title":"Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer:a multidisciplinary systematic review and critical analysis","volume":"74","author":"Wu","year":"2022","journal-title":"Minerva Urol Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040693","article-title":"Outcomes and techniques of robotic-assisted partial nephrectomy (RAPN) for renal hilar masses: A comprehensive systematic review","volume":"16","author":"Pandolfo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.903123","article-title":"Survival\u00a0impact of nephroureterectomy for de novo stage IV nonmetastatic and metastatic upper tract urothelial carcinoma","volume":"9","author":"Lin","year":"2022","journal-title":"Front Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-023-04330-1","article-title":"The role of perioperative chemotherapy for upper tract urothelial carcinoma patients\u00a0treated with radical nephroureterectomy","volume":"41","author":"Pinar","year":"2023","journal-title":"World J Urol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12894-023-01210-z","article-title":"Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy","volume":"23","author":"Anraku","year":"2023","journal-title":"BMC Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01460-y","article-title":"Lymph node dissection in upper tract urothelial carcinoma: current status and future perspectives","volume":"25","author":"D\u0142ubak","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102220","article-title":"Survival outcomes by race following surgical treatment for upper tract urothelial carcinoma","volume":"22","author":"Zappia","year":"2024","journal-title":"Clin\u00a0Genitourin Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.969106","article-title":"Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1480790\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:18:07Z","timestamp":1740633487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1480790\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":26,"alternative-id":["10.3389\/fonc.2025.1480790"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1480790","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"article-number":"1480790"}}